Novalis Biotech
@noval.is
Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics.
Novalis Biotech's Company Logos
Novalis Biotech's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#005AB4
Endeavour
0, 90, 180
210, 100, 35
100, 50, 0, 29
#F5F8FB
Black Squeeze
245, 248, 251
210, 43, 97
2, 1, 0, 2
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Novalis Biotech
Novalis Biotech is a pioneering venture capital fund in the field of life sciences, specializing in early-stage investments. With a strong focus on the convergence of bioinformatics and life sciences, we aim to leverage innovative information technology to advance disease prevention, diagnosis, and treatment. Our investment philosophy revolves around capital-light business models and platform technology, allowing us to remain agile and adaptable to the evolving needs of our portfolio companies.
Founded by esteemed individuals, Prof. Wim Van Criekinge and Jan Van den Berghe, Novalis Biotech stands out for its dynamic and flexible approach. Unlike other funds, we are not confined to specific fields of expertise, welcoming discussions on any proposition within the life sciences realm.
We are proud to have a diverse management team and a dedicated board and advisory panel, consisting of seasoned professionals and industry experts. At Novalis Biotech, our mission is to drive innovation and positive change in the life sciences sector, advocating for the application of cutting-edge technologies and solutions to tackle today's healthcare challenges
Company type
Public Company
Year founded
2018
Company size
2-10 employees
